ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,454Medicare Part D Prescriptions Filled, Including Refills

Rank: 44 out of 223

$681K Total Retail Price of All Prescriptions

Rank: 31 out of 223

460 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
26% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Utah
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 460 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

14% of this provider’s 460 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 7,553 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$72 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Utah
OMEPRAZOLE 430 362 1 3
LISINOPRIL 418 375 2 4
SIMVASTATIN 378 321 3 1
LEVOTHYROXINE SODIUM 370 322 4 2
HYDROCODONE-ACETAMINOPHEN 325 195 S3 5 5
GABAPENTIN 230 156 6 10
ZOLPIDEM TARTRATE 226 176 7 8
METFORMIN HCL 222 183 8 7
HYDROCHLOROTHIAZIDE 206 182 9 13
FUROSEMIDE 184 149 10 9
MELOXICAM 167 144 11 33
AMLODIPINE BESYLATE 159 147 12 6
CRESTOR 156 138 13 37
PRAVASTATIN SODIUM 153 126 14 15
POTASSIUM CHLORIDE 150 129 15 12
TRAZODONE HCL 147 127 16 22
WARFARIN SODIUM 140 119 17 11
METOPROLOL TARTRATE 122 116 18 25
CITALOPRAM HBR 121 93 19 16
ALLOPURINOL 120 87 20 28
ATORVASTATIN CALCIUM 119 108 21 17
TRAMADOL HCL 118 108 22 18
ATENOLOL 109 87 23 32
LOSARTAN POTASSIUM 104 98 24 14
METOPROLOL SUCCINATE 102 95 25 20
ADVAIR DISKUS 90 57 26 47
ZETIA 86 53 27 68
SERTRALINE HCL 81 73 28 21
ALENDRONATE SODIUM 80 72 29 19
CELEBREX 73 64 30 42
DIOVAN 72 64 31 54
CARVEDILOL 72 56 31 23
FLUOXETINE HCL 69 58 33 24
GLIMEPIRIDE 68 61 34 30
PREDNISONE 67 55 35 43
PROAIR HFA 66 44 36 64
CYMBALTA 65 45 37 40
FENOFIBRATE 65 50 37 38
RANITIDINE HCL 62 43 39 65
IBUPROFEN 56 23 40 46
LOSARTAN-HYDROCHLOROTHIAZIDE 56 54 40 31
FINASTERIDE 55 47 42 58
OXYCODONE HCL-ACETAMINOPHEN 52 43 S2 43 106
TAMSULOSIN HCL 51 46 44 26
BUPROPION HCL SR 51 39 44 72
VENLAFAXINE HCL ER 51 39 44 83
CARISOPRODOL 50 16 R 47 63
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 20, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.